Natural health product · NPN 80073807
CONCENTRIA
Yes: licensed in Canada
The product licence is active. Whether the product is actually on the market is a separate, voluntary notice; the official record shows it.
Licence status Active; licensed November 16, 2016.
- Natural Product Number (NPN)
- 80073807
- Licence holder
- Nova-Pharma
- Dosage form
- Capsule
- Route
- Oral
- Licensing route
- Non-Traditional
- First licensed
- November 16, 2016
Medicinal ingredients
Per dosage unit, as licensed.
| Ingredient | Amount | Source and potency |
|---|---|---|
| 1,3,7-Trimethylxanthine | 200 milligrams | Coffea arabica seed |
| 1,3,7-Trimethylxanthine | 200 milligrams | Caffeine |
| Ginkgo biloba | 160 milligrams | Ginkgo biloba - leaf; 36.8 milligrams Flavoglycosides; 50:1 Dry; equivalent to 8000 milligrams dried herb |
| Ginkgo biloba | — | Ginkgo biloba - leaf; 9.6 milligrams Terpéno-lactones |
| Citrus aurantium | 30 milligrams | Citrus aurantifolia - Fruit; 4 % Synéphrine; 10:1 Dry; equivalent to 300 milligrams dried herb |
| L-alpha-Glycerophosphorylcholine | 200 milligrams | Choline alfoscerate |
What it is licensed for
The licence’s own wording. Directions, doses, cautions and warnings are on the official record and the label.
- N/A
Non-medicinal ingredients
Microcrystalline cellulose; Maltodextrin; Magnesium Stearate; Gelatin